Trials / Recruiting
RecruitingNCT06945120
ACT Lung Health Intervention: Phase Two
Efficacy of an Asian Culture-tailored Lung Health (ACT) Intervention on Lung Cancer Screening and Smoking Cessation in Asian Americans
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.
Detailed description
This two-arm stratified randomized clinical trial is to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer. Participants will be randomized into one of two groups: Group A: ACT Lung Health Intervention versus Group B: Standard Care. Randomization means a participant is placed into a study group by chance. The research study procedures include screening for eligibility, questionnaires, and saliva tests. It is expected participation in this study will last about 6 months. About 50 participants are expected to take part in this research study. The National Cancer Institute is providing funding for this trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | ACT Lung Health Intervention | An Asian culture-tailored lung health intervention, which includes individual counseling sessions, family coaching, provision of nicotine replacement therapy (NRT) in the form of patches, lozenges, or chewing gum, and educational materials about low-dose computed tomography (LDCT) for lung cancer screening. The eight weekly, counseling sessions with study staff will be conducted via phone call or the Zoom web-conferencing platform. |
Timeline
- Start date
- 2025-11-04
- Primary completion
- 2026-11-30
- Completion
- 2026-12-31
- First posted
- 2025-04-25
- Last updated
- 2026-03-13
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06945120. Inclusion in this directory is not an endorsement.